Cargando…

Advances in virtual screening

Although the term virtual screening as the in silico analog of high throughput screening has been coined only a decade ago, virtual screening is now a widespread lead identification method in the pharmaceutical industry. A myriad of different methods have been developed exploiting the growing librar...

Descripción completa

Detalles Bibliográficos
Autores principales: Muegge, Ingo, Oloff, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105922/
http://dx.doi.org/10.1016/j.ddtec.2006.12.002
_version_ 1783512502319972352
author Muegge, Ingo
Oloff, Scott
author_facet Muegge, Ingo
Oloff, Scott
author_sort Muegge, Ingo
collection PubMed
description Although the term virtual screening as the in silico analog of high throughput screening has been coined only a decade ago, virtual screening is now a widespread lead identification method in the pharmaceutical industry. A myriad of different methods have been developed exploiting the growing library of target structures and assay data as a basis for finding new lead structures. Exploiting synergies between different methods best utilizes the information available and is at the center of recent developments.
format Online
Article
Text
id pubmed-7105922
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71059222020-03-31 Advances in virtual screening Muegge, Ingo Oloff, Scott Drug Discov Today Technol Article Although the term virtual screening as the in silico analog of high throughput screening has been coined only a decade ago, virtual screening is now a widespread lead identification method in the pharmaceutical industry. A myriad of different methods have been developed exploiting the growing library of target structures and assay data as a basis for finding new lead structures. Exploiting synergies between different methods best utilizes the information available and is at the center of recent developments. Elsevier Ltd. 2006 2007-01-12 /pmc/articles/PMC7105922/ http://dx.doi.org/10.1016/j.ddtec.2006.12.002 Text en Copyright © 2006 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Muegge, Ingo
Oloff, Scott
Advances in virtual screening
title Advances in virtual screening
title_full Advances in virtual screening
title_fullStr Advances in virtual screening
title_full_unstemmed Advances in virtual screening
title_short Advances in virtual screening
title_sort advances in virtual screening
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105922/
http://dx.doi.org/10.1016/j.ddtec.2006.12.002
work_keys_str_mv AT mueggeingo advancesinvirtualscreening
AT oloffscott advancesinvirtualscreening